Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Neogenomics Inc (NASDAQ:NEO)

8.40
Delayed Data
As of Jan 23
 -0.10 / -1.18%
Today’s Change
5.49
Today|||52-Week Range
9.88
-1.98%
Year-to-Date
No recent news for Neogenomics Inc.

Today’s Trading

Previous close8.50
Today’s open8.52
Day’s range8.35 - 8.53
Volume173,478
Average volume (3 months)298,788
Market cap$667.4M
Dividend yield--
Data as of 3:59pm ET, 01/23/2017

Growth & Valuation

Earnings growth (last year)-300.00%
Earnings growth (this year)+130.00%
Earnings growth (next 5 years)+20.00%
Revenue growth (last year)+14.62%
P/E ratioNM
Price/Sales4.77
Price/Book3.08

Competitors

 Today’s
change
Today’s
% change
FMIFoundation Medicine ...-0.10-0.54%
NTRANatera Inc-0.48-5.05%
GHDXGenomic Health Inc-0.30-1.09%
NVTAInvitae Corp+0.56+6.58%
Data as of 4:02pm ET, 01/23/2017

Financials

Next reporting dateFebruary 16, 2017
EPS forecast (this quarter)$0.03
Annual revenue (last year)$99.8M
Annual profit (last year)-$2.5M
Net profit margin-2.54%

Profile

Sector
Health Services
Industry
Medical/Nursing Services
Executive Chairman &
Chief Executive Officer
Douglas M. Van Oort
Vice President-
Operations
Mark Machulcz
Corporate headquarters
Fort Myers, Florida

Forecasts


Search for Jobs